[1]
L. . Lei and Z. . Weidong, “Small molecule TKI inhibitors affect the development of non-small cell carcinoma through HIPPO/YAP/PD-L1”,
Cell Mol Biol (Noisy-le-grand)
, vol. 67, no. 5, pp. 117–122, Feb. 2022.